Press Release
Breakthrough discovery to transform prostate cancer treatment
June 25, 2020
Breakthrough discovery to transform prostate cancer treatment
A novel formulation of the prostate cancer drug abiraterone acetate will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials show the new formulation improves the drug’s effectiveness by 40 per cent.
Supercharged ellipsoidal “rugby ball-shaped” polymersomes show hope for booting children’s cancer.
A rugby ball-shaped nanoparticle supercharged with cancer-killing drugs could revolutionise the treatment of one of the most common brain tumours in children.
Researcher awarded $645,205 for biocompatible Gadolinium-free contrast agents for molecular targeted MR imaging
Building on the biomedical engineering of USPIOs, the team expects to generate new probing tools for non-invasive molecular imaging and affect subsequent clinical imaging through earlier and more accurate diagnosis of diseases.
Grant awarded to improve the delivery efficiency of nanomedicines to tumour tissue
Improving the Delivery Efficiency of Nanomedicines to Tumour Tissue - an NHMRC Emerging Leadership Investigator grant awarded to CBNS researcher Dr Changkui Fu
Time to re-analyse experimental data in a quantitative way
Generating timecourse data on targeted or stealthy systems interacting with cells? Then you'll be interested in this new tool from CBNS and UoM researchers. This tool is designed to re-analyse experimental data in a quantitative way, enabling us to compare different particles and cells.
The CBNS 2019 Annual Report is now LIVE
The report presents our research program. It captures the highlights of our various engagement activities and achievements. The 2019 Annual Report, along with the previous year's report can be found on the Annual Reports section of our website.
